Pathogenesis of systemic lupus erythematosus (SLE)

Clinical and Experimental Allergy

Volumn 31, Issue 5, 2001, Pages 678-685

  Robson, Michael G ^a   Walport, Mark J ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; AUTOANTIBODY; AUTOANTIGEN; COMPLEMENT; CYTOKINE; DNA; IMMUNOGLOBULIN G ANTIBODY; LYMPHOTOXIN; MAJOR HISTOCOMPATIBILITY ANTIGEN; PROTEIN; RIBONUCLEOPROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ANTIBODY PRODUCTION; ANTIGEN ANTIBODY COMPLEX; B LYMPHOCYTE; CONFERENCE PAPER; ENVIRONMENTAL FACTOR; HUMAN; IMMUNE RESPONSE; INFLAMMATION; LYMPHOCYTE ACTIVATION; MAJOR HISTOCOMPATIBILITY COMPLEX; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE;

ANIMALS; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC;

EID: 0034846806     PISSN: 09547894     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2222.2001.01147.x     Document Type: Conference Paper

References (84)

1. The clinical presentation of systemic lupus erythematosus
2. Antibodies to nonhistone antigens in systemic lupus erythematosus
3. Hematology: Coagulation problems
4. Low-molecular weight C1q-binding immunoglobulin G in patients with systemic lupus erythematosus consists of autoantibodies to the collagen-like region of C1q
5. IgG autoantibodies against C1q are correlated with nephritis, hypocomplementemia, and dsDNA antibodies in systemic lupus erythematosus
6. A revised estimate of twin concordance in systemic lupus erythematosus
7. Genetic susceptibility to systemic lupus erythematosus
8. Genetic dissection of lupus pathogenesis: A recipe for nephrophilic autoantibodies
9. Systemic lupus erythematosus, complement deficiency and apoptosis
10. Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand
11. Induction of various autoantibodies by mutant gene lpr in several strains of mice
12. The mouse Fas-ligand gene is mutated in gld mice and is part of a TNF family gene cluster
13. Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome
14. Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity
15. Fc gamma RIIA alleles are heritable risk factors for lupus nephritis in African Americans
16. The Fc gamma RIIIA-158F allele is a risk factor for systemic lupus erythematosus
17. Searching for genes in complex diseases: Lessons from systemic lupus erythematosus
18. Autoimmune disease and parasitic infections in Nigerians
19. Antibodies to histones in drug-induced and idiopathic lupus erythematosus
20. Anti-nuclear antibody production and immune-complex glomerulonephritis in BALB/c mice treated with pristane
21. Induction of murine autoimmune disease by chronic polyclonal B cell activation
22. Diet-induced systemic lupus erythematosus (SLE) in primates
23. Systemic lupus erythematosus-like syndrome in monkeys fed alfalfa sprouts: Role of a nonprotein amino acid
24. An increased prevalence of Epstein-Barr virus infection in young patients suggests a possible etiology for systemic lupus erythematosus
25. Canine systemic lupus erythematosus. Transmission of serologic abnormalities by cell-free filtrates
26. Familial lupus erythematosus. Antibodies to DNA in household dogs
27. Autoantibodies in pet dogs owned by patients with systemic lupus erythematosus
28. Autoantibodies in human contacts of SLE dogs
29. The absence of evidence suggesting that systemic lupus erythematosus is a zoonosis of dogs
30. An epidemiologic study of households exposed to canine systemic lupus erythematosus
31. Transplantation of autoimmune potential. I. Development of antinuclear antibodies in H-2 histocompatible recipients of bone marrow from New Zealand Black mice
32. The role of B cells in lpr/lpr-induced autoimmunity
33. Modification of NZB-NZW F1 autoimmune disease by development of tolerance to DNA
34. Genetic and structural evidence for antigen selection of anti-DNA antibodies
35. Successful treatment of autoimmunity in NZB/NZW F1 mice with monoclonal antibody to L3T4
36. Prevention of nephritis in major histocompatibility complex class II-deficient MRL-lpr mice
37. Interaction between CD40 and its ligand gp39 in the development of murine lupus nephritis
38. Treatment of murine lupus with CTLA4Ig
39. Long-term inhibition of murine lupus by brief simultaneous blockade of the B7/CD28 and CD40/gp39 costimulation pathways
40. Major peptide autoepitopes for nucleosome-specific T cells of human lupus
41. Antigen-specific therapy of murine lupus nephritis using nucleosomal peptides: Tolerance spreading impairs pathogenic function of autoimmune T and B cells
42. Nucleosome: A major immunogen for pathogenic autoantibody-inducing T cells of lupus
43. Promiscuous presentation and recognition of nucleosomal autoepitopes in lupus: Role of autoimmune T cell receptor alpha chain
44. Nucleosomal peptide epitopes for nephritis-inducing T helper cells of murine lupus
45. A peptide derived from an autoantibody can stimulate T cells in the (NZB × NZW) F1 mouse model of systemic lupus erythematosus
46. T cell determinants from autoantibodies to DNA can upregulate autoimmunity in murine systemic lupus erythematosus
47. Immune tolerance to autoantibody-derived peptides delays development of autoimmunity in murine lupus
48. Polyclonal B cell activation in lupus-prone mice precedes and predicts the development of autoimmune disease
49. Multiple defects in the immune system of Lyn-deficient mice, culminating in autoimmune disease
50. Deficiency in CD22, a B cell-specific inhibitory receptor, is sufficient to predispose to development of high affinity autoantibodies
51. B and T cells are not required for the viable motheaten phenotype
52. Spontaneous autoimmune disease in Fc (gamma) RIIB-deficient mice results from strain-specific epistasis
53. Polygenic autoimmune traits: Lyn, CD22, and SHP-1 are limiting elements of a biochemical pathway regulating BCR signaling and selection
54. Impaired Fas response and autoimmunity in Pten+/- mice
55. The cell cycle inhibitor p21 controls T-cell proliferation and sex-linked lupus development
56. Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor
57. Allogeneic MHC antigen requirements for lupus-like autoantibody production and nephritis in murine graft-vs-host disease
58. Autoimmunization in murine graft-vs-host disease. I. Selective production of antibodies to histones and DNA
59. A systemic lupus erythematosus (SLE)-like disease in mice induced by abnormal T-B cell cooperation. Preferential formation of autoantibodies characteristic of SLE
60. Deficiency of the effector mechanisms of the immune response and autoimmunity
61. Phagocyte recognition of cells undergoing apoptosis
62. Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes
63. C1q binds directly and specifically to surface blebs of apoptotic human keratinocytes: Complement deficiency and systemic lupus erythematosus revisited
64. Systemic exposure to irradiated apoptotic cells induces autoantibody production
65. Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies
66. A hierarchical role for classical pathway complement proteins in the clearance of apoptotic cells
67. Lupus, DNase and defective disposal of cellular debris
68. Serum amyloid P component controls chromatin degradation and prevents antinuclear autoimmunity
69. Features of systemic lupus erythematosus in Dnase1-deficient mice
70. Deficiency in serum immunoglobulin (Ig) M predisposes to development of IgG autoantibodies
71. Accelerated development of IgG autoantibodies and autoimmune disease in the absence of secreted IgM
72. Immunological studies concerning the nephritis of systemic lupus erythematosus
73. Polyreactive autoantibodies are nephritogenic in murine lupus nephritis
74. Restricted subpopulations of DNA antibodies in kidneys of mice with systemic lupus. Comparison of antibodies in serum and renal eluates
75. Distinct clonotypes of anti-DNA antibodies in mice with lupus nephritis
76. Ultrastructural localization of DNA in immune deposits of human lupus nephritis
77. A role for histones and ubiquitin in lupus nephritis?
78. Histone mediates glomerular deposition of small size DNA anti-DNA complex
79. Anti-nucleosome antibodies complexed to nucleosomal antigens show anti-DNA reactivity and bind to rat glomerular basement membrane in vivo
80. Antigen specificity of anti-nuclear antibodies complexed to nucleosomes determines glomerular basement membrane binding in vivo
81. Anti-DNA antibodies can bind to the glomerulus via two distinct mechanisms
82. Uncoupling of immune complex formation and kidney damage in autoimmune glomerulonephritis
83. Cutting edge: C1q protects against the development of glomerulonephritis independently of C3 activation
84. Amelioration of lupus-like autoimmune disease in NZB/WF1 mice after treatment with a blocking monoclonal antibody specific for complement component C5